Prostacyclin inhibits adhesion of polymorphonuclear leukocytes to human vascular endothelial cells due to adhesion molecule independent regulatory mechanisms

Basic Research in Cardiology

Volumn 98, Issue 1, 2003, Pages 8-15

  Lindeman, Stephan ^a   Gierer, Claudia ^a   Darius, Harald ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adhesion; Chemotaxis; Leukocytes; Platelet activating factor; Prostacyclin analogs

Indexed keywords

APAFANT; CELL ADHESION MOLECULE; CHEMOATTRACTANT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ILOPROST; INTERCELLULAR ADHESION MOLECULE 1; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E1; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD VESSEL WALL; CELL ACTIVATION; CELL ACTIVITY; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; ISCHEMIA; LEUKOCYTE ADHERENCE; MICROSCOPY; NEUTROPHIL; NORMAL HUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPERFUSION INJURY; SUPERNATANT; UMBILICAL VEIN;

ALPROSTADIL; CELL ADHESION; CELL ADHESION MOLECULES; CELL NUCLEUS; CELLS, CULTURED; CHEMOTAXIS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HUMANS; ILOPROST; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037255689     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-003-0383-1     Document Type: Article

References (22)

1. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016-1023
2. Simpson PJ, Todd RF, 3rd, Mickelson JK, Fantone JC, Gallagher KP, Lee KA, Tamura Y, Cronin M, Lucchesi BR (1990) Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. Circulation 81: 226-237
3. Darius H, Osborne JA, Reibel DK, Lefer AM (1987) Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium. J Mol Cell Cardiol 19: 243-250
4. Schror K, Ohlendorf R, Darius H (1981) Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia. J Pharmacol Exp Ther 219: 243-249
5. Smith EF, 3rd, Gallenkamper W, Beckmann R, Thomsen T, Mannesmann G, Schror K (1984) Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): Effects on myocardial preservation, collateral blood flow and infarct size. Cardiovasc Res 18: 163-173
6. Farber NE, Pieper GM, Thomas JP, Gross GJ (1988) Beneficial effects of iloprost in the stunned canine myocardium. Circ Res 62: 204-215
7. Darius H, Thomsen T, Schror K (1987) Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist. J Cardiovasc Pharmacol 10: 144-152
8. Simpson PJ, Mickelson J, Fantone JC, Gallagher KP, Lucchesi BR (1987) Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart. Circ Res 60: 666-673
9. Simpson PJ, Mitsos SE, Ventura A, Gallagher KP, Fantone JC, Abrams GD, Schork MA, Lucchesi BR (1987) Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 113: 129-137
10. Jones G, Hurley JV (1984) The effect of prostacyclin on the adhesion of leucocytes to injured vascular endothelium. J Pathol 142: 51-59
11. Araki H, Lefer AM (1980) Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart. Circ Res 47: 757-763
12. Fantone JC, Kinnes DA (1983) Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun 113: 506-512
13. Riva CM, Morganroth ML, Ljungman AG, Schoeneich SO, Marks RM, Todd RF, 3rd, Ward PA, Boxer LA (1990) Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am J Respir Cell Mol Biol 3: 301-309
14. Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756
15. Lindemann S, Sharafi M, Spiecker M, Buerke M, Fisch A, Grosser T, Veit K, Gierer C, Ibe W, Meyer J, Darius H (2000) NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thromb Res 97: 113-123
16. Boxer LA, Oliver JM, Spielberg SP, Allen JM, Schulman JD (1979) Protection of granulocytes by vitamin E in glutathione synthetase deficiency. N Engl J Med 301: 901-905
17. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A 93: 9114-9119
18. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68
19. Zimmerman G, Klein-Knoeckel D (1986) Human endothelial cells inhibit granulocyte aggregation in vitro. J Immunol 136: 3839-3834
20. Auchampach JA, Pieper GM, Cavero I, Gross GJ (1998) Effect of platelet-activating factor antagonist RP 59227 (Tulopfant) on myocardial ischemia/reperfusion injury and neutrophil function. Basic Res Cardiol 93: 361-371
21. McIntyre TM, Zimmermann GA, Satoh K, Prescott SM (1985) Cultured endothelial cells synthetize cyclin in response to histamin, bradykinin, and adenosine triphosphate. J Clin Invest 76: 271-280
22. Bussolino F, Camussi G, Baglioni C (1988) Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J Biol Chem 263: 11856-11861